ABT — Abbott Laboratories COM

Ownership history in D.A. DAVIDSON & CO.  ·  93 quarters on record

This page tracks every 13F SEC filing in which D.A. DAVIDSON & CO. reported a position in Abbott Laboratories COM (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.07% (2011 Q3)
Avg. % of fund
0.21%
First filed
1999 Q2
Last filed
2025 Q4
Quarters held
93
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 182,233 +182,231 +9111550.0% 0.14% $22.8M $124.66
2025 Q3 REDUCED 2 -166,604 -100.0% 0.00% $6 $132.67
2025 Q3 ADDED 166,606 +1,734 +1.1% 0.14% $22.3M $132.67
2025 Q2 REDUCED 164,872 -1,804 -1.1% 0.16% $22.4M $134.12
89 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ABT price (monthly, adj. close)

Other funds also holding ABT

As of 2025 Q4 — sorted by position size

Livelsberger Financial Advisory 16.33% CURA WEALTH ADVISORS, LLC 10.82% PATRICK M SWEENEY & ASSOCIATES, INC 5.83% Sugar Maple Asset Management, LLC 5.64% Milestone Resources Group Ltd 3Y 7Y 5.58% COERENTE CAPITAL MANAGEMENT 3Y 5.06% Tandem Investment Advisors, Inc. 3Y 7Y 4.63% America First Investment Advisors, LLC 3Y 7Y 4.54% HENDLEY & CO INC 3Y 7Y 4.45% Bruce & Co., Inc. 3Y 7Y 4.42%
← Back to D.A. DAVIDSON & CO. Holdings